Mitchell Creem - Net Worth and Insider Trading

Mitchell Creem Net Worth

The estimated net worth of Mitchell Creem is at least $206,608 dollars as of 2024-05-01. Mitchell Creem is the Director of Clinigence Holdings Inc and owns about 31,746 shares of Clinigence Holdings Inc (CLNH) stock worth over $203,174. Mitchell Creem is also the Director of Nutex Health Inc and owns about 5,450 shares of Nutex Health Inc (NUTX) stock worth over $3,434. Details can be seen in Mitchell Creem's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mitchell Creem has not made any transactions after 2023-06-14 and currently still holds the listed stock(s).

Transaction Summary of Mitchell Creem

To

Mitchell Creem Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mitchell Creem owns 3 companies in total, including Clinigence Holdings Inc (CLNH) , Astrana Health Inc (ASTH) , and Nutex Health Inc (NUTX) .

Click here to see the complete history of Mitchell Creem’s form 4 insider trades.

Insider Ownership Summary of Mitchell Creem

Ticker Comapny Transaction Date Type of Owner
CLNH Clinigence Holdings Inc 2020-08-12 director
ASTH Astrana Health Inc 2014-08-25 director & Chief Financial Officer
NUTX Nutex Health Inc 2023-06-14 director

Mitchell Creem Latest Holdings Summary

Mitchell Creem currently owns a total of 2 stocks. Among these stocks, Mitchell Creem owns 31,746 shares of Clinigence Holdings Inc (CLNH) as of August 12, 2020, with a value of $203,174 and a weighting of 98.34%. Mitchell Creem also owns 5,450 shares of Nutex Health Inc (NUTX) as of June 14, 2023, with a value of $3,434 and a weighting of 1.66%.

Latest Holdings of Mitchell Creem

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CLNH Clinigence Holdings Inc 2020-08-12 31,746 6.40 203,174
NUTX Nutex Health Inc 2023-06-14 5,450 0.63 3,434

Holding Weightings of Mitchell Creem


Mitchell Creem Form 4 Trading Tracker

According to the SEC Form 4 filings, Mitchell Creem has made a total of 1 transactions in Clinigence Holdings Inc (CLNH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Clinigence Holdings Inc is the acquisition of 31,746 shares on August 12, 2020, which cost Mitchell Creem around $635 Million.

According to the SEC Form 4 filings, Mitchell Creem has made a total of 1 transactions in Nutex Health Inc (NUTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Nutex Health Inc is the acquisition of 3,333 shares on June 14, 2023, which cost Mitchell Creem around $21,500.

Insider Trading History of Mitchell Creem

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mitchell Creem Trading Performance

GuruFocus tracks the stock performance after each of Mitchell Creem's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mitchell Creem is -29.16%. GuruFocus also compares Mitchell Creem's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mitchell Creem within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mitchell Creem's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mitchell Creem

Average Return

92.31%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.8 -29.16 5.84 92.31
Relative Return to S&P 500(%) 7.86 -32.99 -6.33 60.35

Mitchell Creem Ownership Network

Ownership Network List of Mitchell Creem

No Data

Ownership Network Relation of Mitchell Creem


Mitchell Creem Owned Company Details

What does Clinigence Holdings Inc do?

Who are the key executives at Clinigence Holdings Inc?

Mitchell Creem is the director of Clinigence Holdings Inc. Other key executives at Clinigence Holdings Inc include director & 10 percent owner Terence Martin Breslin , Chief Executive Officer Lawrence Schimmel , and director & Chief Financial Officer Elisa V Luqman .

Clinigence Holdings Inc (CLNH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Clinigence Holdings Inc (CLNH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clinigence Holdings Inc (CLNH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Clinigence Holdings Inc (CLNH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Clinigence Holdings Inc Insider Transactions

No Available Data

Mitchell Creem Mailing Address

Above is the net worth, insider trading, and ownership report for Mitchell Creem. You might contact Mitchell Creem via mailing address: 700 North Brand Blvd., Suite 450, Glendale Ca 91203.

Discussions on Mitchell Creem

No discussions yet.